What is Critical Medicines Act?
EU regulatory framework to strengthen the availability and security of supply of critical medicinal products, addressing shortages and strategic dependencies in the pharmaceutical sector.
Critical Medicines Act
EU regulatory framework to strengthen the availability and security of supply of critical medicinal products, addressing shortages and strategic dependencies in the pharmaceutical sector.
See current Critical Medicines Act activity, then check whether the developments map to your products, sites, suppliers, markets, and internal owners.
Book a demo
Prefer to self-diagnose first? Get a free exposure assessment
Current activity
Intensifying
167% above the prior 8-week baseline
3-month trend
43 alerts tracked
Updated 1 July 2026, 07:08
Topic context
How to read Critical Medicines Act regulatory activity
Why it matters
Critical Medicines Act developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.
How Foresight monitors it
Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.
Frequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
